**Correction to:** *Cell Death and Disease* (2011) **2**, e185; Published online 28 July 2011; doi:[10.1038/cddis.2011.64](/doifinder/10.1038/cddis.2011.64)

Since the publication of the article, the Authors and Editors have determined that [Figure 3a](#fig3){ref-type="fig"} was incorrect. The figure below is the correct version.

The authors would like to apologize for this error.

![Effects of the combination of celecoxib and ABL on COX-2 expression and activity in MDA-MD-231 cells. (**a**) MDA-MD-231 cells were treated with celecoxib, ABL or their combination for 24 h (left) or 48 h (right). COX-2 mRNA and protein expression was examined using RT-PCR (left) and western blot analysis (right). Quantification of COX-2 mRNA and protein expression normalized to actin levels, were provided at the bottom. (**b**) MDA-MB-231 cells were treated with the combination for 48 h, and PGE~2~ levels in the culture medium were measured using ELISA. Results were expressed as mean±S.E.M. from at least three independent experiments](cddis201192f3){#fig3}
